Clinical Trial Update: Soy Isoflavones in Preventing Head and Neck Cancer Recurrence in Patients With Stage I-IV Head and Neck Cancer Undergoing Surgery [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating whether soy isoflavones can prevent recurrence of head and neck squamous cell carcinomas after surgery; results were posted in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma
• Hypopharyngeal Squamous Cell Carcinoma
• Laryngeal Squamous Cell Carcinoma
• Lip and Oral Cavity Squamous Cell Carcinoma
• Oral Cavity Squamous Cell Carcinoma
• Oropharyngeal Squamous Cell Carcinoma
• Tongue Carcinoma
• Verrucous Carcinoma

Drugs mentioned

• Soy Isoflavones (isoflavones from soy)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Recurrent Hypopharyngeal Squamous Cell Carcinoma, Recurrent Laryngeal Squamous Cell Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2016-10-24